Home > Boards > US Listed > Biotechs > Aurinia Pharmaceuticals Inc (AUPH)

amazing how many here are so negative on

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
cervelo Member Profile
 
Followed By 1
Posts 634
Boards Moderated 0
Alias Born 04/11/17
160x600 placeholder
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 9/17/2021 4:04:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2021 5:02:32 PM
Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences Business Wire - 9/15/2021 1:11:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/14/2021 6:17:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/14/2021 5:12:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/14/2021 5:11:39 PM
Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference Business Wire - 9/10/2021 1:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/8/2021 4:05:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/8/2021 4:04:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/27/2021 4:16:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/26/2021 4:16:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/17/2021 4:07:54 PM
Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases Business Wire - 8/17/2021 6:05:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/10/2021 4:09:58 PM
Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotech Conference Business Wire - 8/9/2021 7:55:00 AM
SCWorx, Aurinia Pharmaceuticals leads healthcare gainers; Dicerna Pharmaceuticals, iCAD among major losers Seeking Alpha - 8/6/2021 11:02:32 AM
Aurinia Pharma extends gains following robust Q2 top-line growth Seeking Alpha - 8/6/2021 6:08:45 AM
Aurinia Pharma EPS misses by $0.01, beats on revenue Seeking Alpha - 8/5/2021 4:16:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2021 4:14:46 PM
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights Business Wire - 8/5/2021 4:05:00 PM
Eyes will be on Aurinia's lupus drug Lupkynis during Q2 2021 earnings today Seeking Alpha - 8/5/2021 11:46:57 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/29/2021 4:11:23 PM
Aurinia Pharmaceuticals to Release Second Quarter 2021 Financial Results on August 5, 2021 Business Wire - 7/26/2021 6:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2021 6:02:19 AM
Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange Business Wire - 7/16/2021 5:30:00 PM
cervelo   Thursday, 07/15/21 06:00:49 PM
Re: None
Post # of 13475 
amazing how many here are so negative on others just because they have a differing view of what is happening and why.

Is it shareholders here whom have caused the stock to plummet from 24.00 to under 12.00 dollars. I highly doubt it.

The performance of a stock is based upon the company, it's product and management ability to perform. (company and management are the same thing) at least it was when I owned my company!

And last I noticed the FDA approved the drug so the share value has not lost half of the value because of product.

In the real world management is beholden to shareholder who have provided them the funds to finance the company.

Seems this management has lost sight of that fact.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences